Table 7 Univariate cox regression analyses
SRCC (n = 34) | Non-SRCC (n = 33) | |||||
|---|---|---|---|---|---|---|
N | 5-year overall survival | p | N | 5-year overall survival | p | |
Age | 0.30 | 0.49 | ||||
≤ 60 | 23 | 52.2% | 10 | 60% | ||
>60 | 11 | 36.4% | 23 | 47.8% | ||
Sex | 0.49 | 0.31 | ||||
Female | 19 | 52.6% | 14 | 64.3% | ||
Male | 15 | 40% | 19 | 42.1% | ||
BMI | 0.82 | 0.005 | ||||
≤ 20 | 5 | 40% | 2 | 0% | ||
>20 | 7 | 42.9% | 8 | 37.5% | ||
Hemoglobin rate | 0.49 | 0.46 | ||||
≤ 10 | 5 | 60% | 19 | 47.5% | ||
> 10 | 24 | 41.7% | 12 | 50% | ||
Malnutrition | 0.02 | 0.67 | ||||
Yes | 2 | 0% | 3 | 66.7% | ||
No | 32 | 50% | 30 | 50% | ||
Tumor size | 0.09 | 0.47 | ||||
≤ 80 mm | 22 | 54.5% | 22 | 59.1% | ||
> 80% | 7 | 42.9% | 9 | 33.3% | ||
Linitis plastica | 0.003 | - | ||||
Yes | 7 | 14.3% | 0 | |||
No | 27 | 55.6% | 33 | 51.5% | ||
Carcinomatosis | 0.001 | - | ||||
Yes | 2 | 0% | 0 | |||
No | 32 | 50% | 33 | 51.5% | ||
Gastrectomy | 0.59 | 0.15 | ||||
Total | 29 | 44.8% | 17 | 64.7% | ||
Subtotal | 5 | 60% | 16 | 37.5% | ||
Lymph node dissection | 0.001 | 0.13 | ||||
D1 | 2 | 0% | 2 | 0% | ||
D2 | 32 | 50% | 31 | 54.8% | ||
Dissection quality | 0.001 | 0.006 | ||||
R0 | 25 | 60% | 28 | 60.7% | ||
R1 + R2 | 9 | 11.1% | 5 | 0% | ||
Lymph node involvement | 0.001 | 0.002 | ||||
Yes | 22 | 27.3% | 17 | 29.4% | ||
No | 12 | 83.3% | 15 | 80% | ||
Distal metastasis | 0.02 | |||||
Yes | 0 | 0 | 2 | 0% | ||
No | 34 | 47.1% | 31 | 54.8% | ||
Tumor stage | 0.003 | 0.01 | ||||
I | 10 | 80% | 10 | 80% | ||
II | 8 | 62.5% | 10 | 60% | ||
III | 16 | 18.8% | 11 | 27.3% | ||
IV | 0 | - | 2 | 0% | ||
Complications | 0.37 | 0.24 | ||||
Yes | 4 | 75% | 10 | 40% | ||
No | 30 | 43.3% | 23 | 56.5% | ||
Adjuvant chemotherapy | 0.03 | 0.21 | ||||
Yes | 20 | 30% | 16 | 37.5% | ||
No | 10 | 70% | 13 | 69.2% | ||